MFMaria Alejandra Fonseca-Mora

Maria Alejandra Fonseca-Mora

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Alejandra Fonseca-Mora has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Colombian Ocular Infectious Epidemiology Study (COIES): Herpes Zoster Ophthalmicus prevalence and sociodemographic characterization, 2015-2019

    by Carlos Cifuentes-González, William Rojas-Carabali, Maria Alejandra Fonseca-Mora, German Mejia-Salgado, Juliana Reyes-Guanes, Alejandra De-La-Torre


  • Open Access

    Necrotizing Anterior Scleritis in a Woman with Terrien's Margin Degeneration: A Case Report

    by María Alejandra Fonseca-Mora, Paula Tatiana Muñoz-Vargas, Juliana Reyes-Guanes, William Rojas-Carabali, Miguel Cuevas, Alejandra De-La-Torre

    Purpose: The aim of the study was to report the first case of a patient with Terrien's Marginal Degeneration (TMD) who developed necrotizing anterior scleritis without systemic disease association, requiring systemic immunosuppressive treatment. Case Report: A 32-year-old female consulted for bilateral ocular burning and hyperemia. Initially, she was diagnosed with conjunctivitis and treated with topical antibiotics and corticosteroids, with mild transitory improvement but the progression of the disease. Years later, she attended the immunology consultation for a second opinion where TMD with ocular inflammatory component OU was diagnosed. Seven months later, she presented with severe pain, decreased visual acuity, and photophobia in OS. At the slit-lamp examination, necrotizing anterior scleritis with a high risk of perforation in OS was observed. The patient was referred to the rheumatologist and started treatment with systemic corticosteroids and cyclophosphamide, exhibiting a clinical improvement. The patient did not meet the criteria for any systemic illness associated with scleritis, such as autoimmune diseases or vasculitis. Thus, scleritis was related to the adjacent inflammatory process associated with TMD, as an atypical presentation of this disease. Conclusion: Although an inflammatory type of TMD has been proposed, it is essential to follow up closely these patients and consider necrotizing anterior scleritis, a severe ocular disease that requires prompt immunosuppressive management, as a possible atypical associated presentation of this disease.